fluphenazine has been researched along with Obesity in 2 studies
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
Excerpt | Relevance | Reference |
---|---|---|
"Obesity is associated with increased morbidity and may reduce compliance, leading to a return of psychotic symptoms." | 1.27 | Prevalence of obesity in patients receiving depot antipsychotics. ( Goodall, E; Silverstone, T; Smith, G, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Silverstone, T | 1 |
Smith, G | 1 |
Goodall, E | 1 |
Gonzalez, JR | 1 |
2 other studies available for fluphenazine and Obesity
Article | Year |
---|---|
Prevalence of obesity in patients receiving depot antipsychotics.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Female; Flupenthixol; Fluphenazine; Humans | 1988 |
Extreme sensitivity to phenothiazines in a psychotic patient with Pickwick syndrome.
Topics: Adolescent; Brain Stem; Chlorpromazine; Fluphenazine; Humans; Intellectual Disability; Male; Obesity | 1966 |